Walder Wyss has advised Callista Group. Callista Group has completed the acquisition of Swiss e-bike retailer M-Way from TVS EBike Company AG, an indirect subsidiary of...
Callista Group Acquires Swiss E-Bike Retailer M-Way from TVS Motor Company
CRISPR Therapeutics Issues $600 Million Convertible Senior Notes
Walder Wyss has advised CRISPR Therapeutics. Davis Polk has advised the initial purchasers. CRISPR Therapeutics AG has successfully completed an offering of $600 million aggregate principal...
Claret Capital Partners Invests in Swiss MedTech Company SIS Medical AG
Walder Wyss has advised SIS Medical AG. Wenger Vieli has advised Claret Capital Partners. SIS Medical AG has secured an investment from Claret Capital Partners, as...
Distalmotion Secures $150 Million Series G Financing Led by Revival Healthcare Capital
Wilson Sonsini Goodrich & Rosati and Bär & Karrer have advised Revival Healthcare Capital on the deal. Walder Wyss has advised Distalmotion. Distalmotion SA, a global...
Corient Acquires Stakes in Stonehage Fleming and Stanhope Capital to Form Leading Global Wealth Manager
Travers Smith LLP has advised Caledonia Investments plc. Macfarlanes and Borel & Barbey have advised Stonehage Fleming and Stanhope Capital. Walder Wyss and Skadden have advised...
Public Tender Offer for u-blox by Advent International Subsidiary
Walder Wyss and Freshfields have advised u-blox. Bär & Karrer and Advestra have advised Advent International and its subsidiary ZI Zenith S.à r.l. u-blox Holding AG,...
SoftwareOne Holding AG’s Acquisition Of Crayon Group Holding ASA
Walder Wyss and Lenz & Staehelin advised SoftwareOne Holding on the deal, Bär & Karrer advised Crayon Group Holding, Wikborg Rein advised on the Norwegian law...
Alentis Therapeutics’ $181.4 Million Series D Financing Round
Walder Wyss advised Alentis Therapeutics on the deal. Honigman advised Catalio Capital Management. Alentis Therapeutics raised $181.4 million in Series D financing, supported by a syndicate...
SOPHiA GENETICS SA’s $50 Million Secured Term Loan Financing
Walder Wyss advised the funds managed by Perceptive Advisors, LLC. SOPHiA GENETICS SA (NASDQ: SOPH), a Swiss data-driven medicine software company, closed a secured term loan...
CRISPR Therapeutics’ $280 Million Equity Issuance
Walder Wyss advised CRISPR Therapeutics on the issuance. CRISPR Therapeutics AG (NASDAQ: CRSP), a Switzerland-based biopharmaceutical company focused on creating transformative gene-based medicines for serious diseases,...
Altamira Therapeutics’ Sale Of Majority Stake in Altamira Medica AG
Walder Wyss advised Nasdaq listed Altamira Therapeutics. Altamira Therapeutics Ltd. (Nasdaq: CYTO), a company dedicated to developing therapeutics that address important unmet medical needs, entered into a binding...
OC Oerlikon’s Acquisition of Riri
Lenz & Staehelin advised the selling shareholders of RIRI Group in this transaction. Homburger advised OC Oerlikon. Oerlikon, a global innovation provider for surface engineering, polymer...